GTHXG1 TherapeuticsGTHX info
$7.16info0.14%24h
Global rank13321
Market cap$371.20M
Change 7d0.42%
YTD Performance129.12%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    G1 Therapeutics (GTHX) Stock Overview

    G1 Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, a (CDK) 4/6 inhibitor can protect bone marrow and reduce hematologic adverse events (AEs), as well as improve emerging treatments through myeloprotection which improve patients' overall anti-tumor immune responses combination with the antibody-drug conjugate; and treatment of neoadjuvant breast cancer. In addition, the company develops lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, and HER2-negative breast cancer. The company has a license agreement with EQRx, Inc. and Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat any indication in humans, as well as Nanjing Simcere Dongyuan Pharmaceutical Co., LTD. for the development and commercialization of trilaciclib for any indication in humans through parenteral delivery, and ARC Therapeutics for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina.

    GTHX Stock Information

    Symbol
    GTHX
    Address
    700 Park Offices DriveResearch Triangle Park, NC 27709United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.g1therapeutics.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    919 213 9835

    G1 Therapeutics (GTHX) Price Chart

    -
    Value:-

    G1 Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $7.16
    N/A
    Market Cap
    $371.20M
    N/A
    Shares Outstanding
    51.84M
    N/A
    Employees
    170.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org